231 related articles for article (PubMed ID: 29481911)
1. RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.
Qiu D; Wang Q; Wang Z; Chen J; Yan D; Zhou Y; Li A; Zhang R; Wang S; Zhou J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1552-1561. PubMed ID: 29481911
[TBL] [Abstract][Full Text] [Related]
2. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.
Chen Y; Huang Y; Huang Y; Xia X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Re OD; Li G; Zhou J
Carcinogenesis; 2014 Feb; 35(2):442-51. PubMed ID: 24072772
[TBL] [Abstract][Full Text] [Related]
3. JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients.
Qian J; Zhu W; Wang K; Ma L; Xu J; Xu T; Røe OD; Li A; Zhou J; Shu Y
Oncotarget; 2016 Jun; 7(24):36865-36884. PubMed ID: 27167206
[TBL] [Abstract][Full Text] [Related]
4. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
5. ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation.
Xu SH; Zhu S; Wang Y; Huang JZ; Chen M; Wu QX; He YT; Chen D; Yan GR
Cell Death Dis; 2018 May; 9(5):479. PubMed ID: 29706618
[TBL] [Abstract][Full Text] [Related]
6. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
7. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
[TBL] [Abstract][Full Text] [Related]
8. High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.
Chen Y; Xia X; Wang S; Wu X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Røe OD; Zhou J
J Gastroenterol; 2013 Sep; 48(9):1034-44. PubMed ID: 23307041
[TBL] [Abstract][Full Text] [Related]
9. JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4.
Xu L; Cheng L; Yang F; Pei B; Liu X; Zhou J; Zhu Y; Wang S
Mol Med Rep; 2018 Jun; 17(6):8137-8144. PubMed ID: 29658570
[TBL] [Abstract][Full Text] [Related]
10. MDM2 is a useful prognostic biomarker for resectable gastric cancer.
Ye Y; Li X; Yang J; Miao S; Wang S; Chen Y; Xia X; Wu X; Zhang J; Zhou Y; He S; Tan Y; Qiang F; Li G; Røe OD; Zhou J
Cancer Sci; 2013 May; 104(5):590-8. PubMed ID: 23347235
[TBL] [Abstract][Full Text] [Related]
11. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
Tao Y; Sun C; Zhang T; Song Y
Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
13. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
[TBL] [Abstract][Full Text] [Related]
14. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.
Deng T; Shen P; Li A; Zhang Z; Yang H; Deng X; Peng X; Hu Z; Tang Z; Liu J; Hou R; Liu Z; Fang W
Theranostics; 2021; 11(16):8112-8128. PubMed ID: 34335983
[TBL] [Abstract][Full Text] [Related]
15. The E3 ligase RNF185 negatively regulates osteogenic differentiation by targeting Dvl2 for degradation.
Zhou Y; Shang H; Zhang C; Liu Y; Zhao Y; Shuang F; Zhong H; Tang J; Hou S
Biochem Biophys Res Commun; 2014 May; 447(3):431-6. PubMed ID: 24727453
[TBL] [Abstract][Full Text] [Related]
16. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer.
Wang S; Wu X; Chen Y; Zhang J; Ding J; Zhou Y; He S; Tan Y; Qiang F; Bai J; Zeng J; Gong Z; Li A; Li G; Røe OD; Zhou J
Clin Cancer Res; 2012 May; 18(10):2987-96. PubMed ID: 22452940
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
19. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
20. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
